Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Foltène (also marketed as Foltène Pharma) is a line of topical dermocosmetic products designed for consumer hair and scalp care, specifically targeting hair loss and thinning. Developed by Foltène Pharma and distributed in certain regions by Profex, the product line features proprietary active ingredients such as Tricalgoxyl (a mixture of polysaccharides from brown algae for women) and Tricosaccaride (for men). Other components include DN-Age (Cassia Alata leaf extract) and Capillia Longa PPF (Curcuma Longa phyto-peptidic fractions). These ingredients work synergistically to strengthen hair follicles, normalize the hair life cycle, and protect the scalp from environmental stressors and premature aging. It is marketed as a consumer health/cosmetic product rather than a pharmaceutical drug and is available in various formulations including scalp treatment vials and shampoos.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Foltène.